Fatos básicos sobre o covid-19, incluindo manifestação clínica, linha do tempo na China e características moleculares do SARS-CoV-2:
1) New England Journal of Medicine. 2020. Clinical Characteristics Of Coronavirus Disease 2019 In China | NEJM. [online] Available at: <https://www.nejm.org/doi/full/10.1056/NEJMoa2002032#article_citing_articles
2) Mapa da pandemia atualizado ao vivo pela OMS: https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd
3) PDF relatando missão conjunta OMS-china: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
4) Andersen, K.G., Rambaut, A., Lipkin, W.I. et al. The proximal origin of SARS-CoV-2. Nat Med (2020). https://doi.org/10.1038/s41591-020-0820-9
5) Zhao, Shi et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak International Journal of Infectious Diseases, Volume 92, 214 - 217
Cloroquina (note que é o primeiríssimo estudo sobre o tema): Gao J, e., 2020. Breakthrough: Chloroquine Phosphate Has Shown Apparent Efficacy In Treatment Of COVID-19 Associated Pneumonia In Clinical Studies. - Pubmed - NCBI. [online] Ncbi.nlm.nih.gov. Available at: <https://www.ncbi.nlm.nih.gov/pubmed/32074550>
Efetividade de outros medicamentos até então (só um de muitos exemplos): New England Journal of Medicine. 2020. A Trial Of Lopinavir–Ritonavir In Adults Hospitalized With Severe Covid-19 | NEJM. [online] Available at: <https://www.nejm.org/doi/full/10.1056/NEJMoa2001282> [Accessed 21 March 2020].
Hipertensão, diabetes e ibuprofeno: Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?Fang, Lei et al. The Lancet Respiratory Medicine, Volume 0, Issue 0
Itália: COVID-19 and Italy: what next?Remuzzi, Andrea et al. The Lancet, Volume 0, Issue 0
Considerações sobre mitigação da pandemia de forma geral: Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD (March 2020). "How will country-based mitigation measures influence the course of the COVID-19 epidemic?". The Lancet. doi:10.1016/S0140-6736(20)30567-5. PMID 32164834.
1) New England Journal of Medicine. 2020. Clinical Characteristics Of Coronavirus Disease 2019 In China | NEJM. [online] Available at: <https://www.nejm.org/doi/full/10.1056/NEJMoa2002032#article_citing_articles
2) Mapa da pandemia atualizado ao vivo pela OMS: https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd
3) PDF relatando missão conjunta OMS-china: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
4) Andersen, K.G., Rambaut, A., Lipkin, W.I. et al. The proximal origin of SARS-CoV-2. Nat Med (2020). https://doi.org/10.1038/s41591-020-0820-9
5) Zhao, Shi et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak International Journal of Infectious Diseases, Volume 92, 214 - 217
Cloroquina (note que é o primeiríssimo estudo sobre o tema): Gao J, e., 2020. Breakthrough: Chloroquine Phosphate Has Shown Apparent Efficacy In Treatment Of COVID-19 Associated Pneumonia In Clinical Studies. - Pubmed - NCBI. [online] Ncbi.nlm.nih.gov. Available at: <https://www.ncbi.nlm.nih.gov/pubmed/32074550>
Efetividade de outros medicamentos até então (só um de muitos exemplos): New England Journal of Medicine. 2020. A Trial Of Lopinavir–Ritonavir In Adults Hospitalized With Severe Covid-19 | NEJM. [online] Available at: <https://www.nejm.org/doi/full/10.1056/NEJMoa2001282> [Accessed 21 March 2020].
Hipertensão, diabetes e ibuprofeno: Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?Fang, Lei et al. The Lancet Respiratory Medicine, Volume 0, Issue 0
Itália: COVID-19 and Italy: what next?Remuzzi, Andrea et al. The Lancet, Volume 0, Issue 0
Considerações sobre mitigação da pandemia de forma geral: Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD (March 2020). "How will country-based mitigation measures influence the course of the COVID-19 epidemic?". The Lancet. doi:10.1016/S0140-6736(20)30567-5. PMID 32164834.
Comentários
Postar um comentário